Pirfenidone
Educational summary, not a formulary. Dosing is quoted from the Makindo chapters and topics site. The other sections are draft summaries not yet checked line by line against the BNF or SPC. Check dose, indication, interactions and monitoring in the BNF entry for Pirfenidone and local guidelines before prescribing.
Mechanism
Antifibrotic with anti-inflammatory action.
Uses
Idiopathic pulmonary fibrosis.
Dosing
No dose is given in the chapters. See the BNF.
Side effects
Nausea, photosensitivity rash, raised LFT, dyspepsia, fatigue.
Interactions
Strong CYP1A2 inhibitors (fluvoxamine, ciprofloxacin) raise levels; smoking reduces levels.
Contraindications and cautions
Severe renal or hepatic impairment
Monitoring
LFT, weight
Pregnancy and breastfeeding
Avoid
Renal and hepatic impairment
Avoid in severe renal or hepatic impairment
Overdose and reversal
Supportive
Special advice
Take with food; sun protection; LFT monthly for first 6 months.
More from the textbook: uses, cautions and other points
- Pirfenidone and nintedanib - slow the decline in lung function (FVC) in idiopathic pulmonary fibrosis ; nintedanib is also used in progressive pulmonary fibrosis from other causes (NICE TAs). They don't reverse existing fibrosis.
Respiratory: Anatomy, Physiology and Pharmacology - Pirfenidone - side effects: photosensitivity rash (sunscreen, cover up), nausea, loss of appetite and weight, fatigue; raised LFTs (monitor monthly at first).
Respiratory: Anatomy, Physiology and Pharmacology - Pirfenidone side effects: photosensitivity rash , nausea, weight loss. Nintedanib side effects: diarrhoea , raised LFTs.
Respiratory: Interstitial Lung Disease - Pirfenidone IPF | Titrated to full dose with food. FVC 50–80% (NICE TA504). Photosensitivity rash (sun protection), nausea, weight loss; monitor LFTs.
Respiratory: Interstitial Lung Disease - Pirfenidone / nintedanib | Antifibrotics for IPF; photosensitivity / diarrhoea; LFTs.
Respiratory: Anatomy, Physiology and Pharmacology - Severe sunburn-like rash on an IPF drug | Pirfenidone photosensitivity
Respiratory: Anatomy, Physiology and Pharmacology - NICE TAs: Biologics for severe asthma; pirfenidone and nintedanib for IPF and progressive fibrosis; CFTR modulators
Respiratory: Anatomy, Physiology and Pharmacology - Pirfenidone or nintedanib for people with FVC 50–80% predicted (NICE TA504, TA379).
Respiratory: Interstitial Lung Disease
Where it is discussed in the book
- Respiratory: Anatomy, Physiology and Pharmacology (5 mentions)
- Respiratory: Interstitial Lung Disease (6 mentions)
- Integrated respiratory chapter (6 mentions)
- 0225 (1 mention)